Search research articles
Contact Us
Filters
Showing results (291-300 of 338) with videos related to
Page
of 34
Sort By:
Blood
|
September 7, 2013
Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon
Giridharan Ramsingh, Meagan A Jacoby, Jin Shao, et al.
Cell Transplantation
|
November 13, 2009
Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart
Ana Carolina M Assis, Juliana L Carvalho, Bruno A Jacoby, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 24, 2006
The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction
Anderson J Ferreira, Bruno A Jacoby, Cícero A A Araújo, et al.
Visual Neuroscience
|
August 5, 2015
Synaptic connections of amacrine cells containing vesicular glutamate transporter 3 in baboon retinas
David W Marshak, Alice Z Chuang, Drew M Dolino, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2000
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18
J K Rasheed, G J Anderson, H Yigit, et al.
Leukemia & Lymphoma
|
April 29, 2016
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome
Mathew A Cherian, Raoul Tibes, Feng Gao, et al.
American Journal of Hematology
|
January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia
Meagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Leukemia Research
|
October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Eric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Health Technology Assessment (Winchester, England)
|
October 2, 2007
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial
A G Marson, R Appleton, G A Baker, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 338) with videos related to
Sort By:
Page
of 34
Blood
|
September 7, 2013
Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon
Giridharan Ramsingh, Meagan A Jacoby, Jin Shao, et al.
Cell Transplantation
|
November 13, 2009
Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart
Ana Carolina M Assis, Juliana L Carvalho, Bruno A Jacoby, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 24, 2006
The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction
Anderson J Ferreira, Bruno A Jacoby, Cícero A A Araújo, et al.
Visual Neuroscience
|
August 5, 2015
Synaptic connections of amacrine cells containing vesicular glutamate transporter 3 in baboon retinas
David W Marshak, Alice Z Chuang, Drew M Dolino, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2000
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18
J K Rasheed, G J Anderson, H Yigit, et al.
Leukemia & Lymphoma
|
April 29, 2016
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome
Mathew A Cherian, Raoul Tibes, Feng Gao, et al.
American Journal of Hematology
|
January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia
Meagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Leukemia Research
|
October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Eric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Health Technology Assessment (Winchester, England)
|
October 2, 2007
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial
A G Marson, R Appleton, G A Baker, et al.
Page
of 34